SCHEMBL5569229

SCHEMBL5569229

CC(=O)NC1=NCCCN1c1ccc(NC(=O)C(N)c2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ USP2 O75604 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ NR4A1 P22736 1/20 0.44
▸ PTK2B Q14289 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ KCNQ2 O43526 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ ROCK2 O75116 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ BAZ1A Q9NRL2 1/20 0.40
▸ F10 P00742 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ EIF2AK3 Q9NZJ5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569317 0.87 ALDH1A1 (0.44) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL5570502 0.86 MAPT (0.46) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL5571203 0.84 MAPT (0.45) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL5566702 0.84 MAPT (0.46) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL5672352 0.80 F10 (0.64) F10
SCHEMBL5571210 0.79 F10 (0.51) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL14454464 0.76 TDP1 (0.41) MAPTKMT2AUSP2POLBALDH1A1
SCHEMBL5569385 0.75 KMT2A (0.48) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL5431564 0.74 MAPT (0.47) MAPTKMT2ANPSR1USP2ESR1
SCHEMBL5445168 0.72 F10 (0.63) F10ACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
Send feedback